Home Compliance Private Equity Settlement Highlights Risks for Investors in Life Sciences Industry ComplianceExpert OpinionFCANews Private Equity Settlement Highlights Risks for Investors in Life Sciences Industry March 10, 2021 14 Share FacebookLinkedinTwitter Sarawut Aiemsinsuk | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance When Advocacy Turns Into Obstruction: A Cautionary Tale for Corporate Counsel Handling Gov’t Investigations Compliance March 2024 Developments Under President Biden’s Cybersecurity Executive Order, National Cybersecurity Strategy, and AI Executive Order Compliance Wages War Over: Ohio Court Rules SCA Violations Weren’t FCA Violations